Early Tamiflu use in nursing homes cuts hospitalisations by 21%

A new study from Brown University's School of Public Health has examined how early and widespread use of Tamiflu can reduce hospitalisations during influenza outbreaks in nursing homes. The findings suggest that treating at least 70% of residents within two days of detecting an outbreak cuts the risk of hospital admission by 21%. The research analysed 404 influenza outbreaks across 318 nursing homes, involving around 30,000 residents. Influenza spreads rapidly in these settings due to shared living spaces and the need for intensive care, making outbreaks a major public health concern.

National guidelines already advise giving antiviral drugs to all eligible residents once an outbreak is identified. However, the study found that achieving universal treatment is often difficult because of medical contraindications or patient refusal. Instead, a 70% coverage target was deemed practical and effective. Timing proved critical. When oseltamivir was administered early to a large proportion of residents, the spread of the virus slowed significantly—similar to the herd immunity effect seen with vaccines. Despite this success in reducing hospitalisations, the study noted no meaningful change in mortality rates, meaning survival outcomes remained unaffected. The study's large and diverse sample size strengthens its conclusions, which are now helping shape clinical guidelines and policies for long-term care facilities.

The results highlight the importance of quick action when influenza outbreaks occur in nursing homes. Treating residents early with antiviral medication can lower hospitalisation rates, though it does not appear to impact death rates. These findings are now guiding updated recommendations for outbreak management in care settings.